Skip to content

Author

Ai-Di Wang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Immune remodeling of tumor-draining lymph nodes: mechanistic determinants of checkpoint blockade responsiveness

The Review links tdLN structural, cellular, and metabolic remodeling to ICB response and resistance, highlights reinforcement of regulatory circuits after metastatic colonization, and discusses translational strategies that incorporate tdLN functional state into therapeutic design.

Cai-Yan Jia, Shu-Xuan Li, Mu-Hua Chen et al. · 0 citations
Review Open access Aug 2026

Emerging targeted therapies for primary immune thrombocytopenia: novel agents, combination strategies, and future directions

This article analyses recent therapeutic trials with Bruton’s tyrosine kinase inhibitors, splenic tyrosine kinase inhibitors, and neonatal Fc receptor antagonists, demonstrating an improvement in platelet counts and patients’ quality of life.

Zhen Wang, Wu-Xia Yang, Nuo Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.